The Many Lanes of Biopharma 


Started your career in R&D and wondering what other paths might be possible? Or curious about where your scientific training can take you beyond the bench? 

Join Soufflé Therapeutics and WEST for a panel conversation with industry professionals who began in R&D and have since moved into diverse areas such as Medical Affairs, CMC, and Regulatory Affairs. Hear how they made the transition, what skills carried over, what they learned along the way, and what they wish they had known earlier.

Whether you're happy at the bench, considering a career pivot, or simply curious about the many paths within biopharma, this conversation will offer practical insights and inspiration for navigating your career.

Panelists include

  • Preeti Joshi, Senior Director of Medical Affairs at Alexion Pharmaceuticals, Inc.
  • Daisy Lam-McMahon, Senior Regulatory Affairs Specialist at Beam Therapeutics
  • Edward Miracco, Head of Enterprise AI Enablement at Moderna.

 

 

Date and Time:  
November 10, 2026
6:00-8:00 PM 

   6:00-6:15pm: Registration, food, networking
   6:15-7:30pm: Panel
   7:30-8:00pm: Optional Networking

Location:  
Soufflé Therapeutics, 250 Arsenal St, Watertown, MA 02472

 

Cost:   
Members: $15; Non-Members: $30

Given our mission is to promote women's development in STEM we would like to offer a free spot in our workshops to those in transition between jobs or who cannot afford the ticket price. Please contact [email protected] if you qualify.

 

Register Here

 

Panelist Bios

Preeti Joshi is Senior Director of Medical Affairs at Alexion Pharmaceuticals, Inc. Prior to that she was Senior Director, Head of Medical Affairs at BlueRock Therapeutics; Director of Medical Affairs at Apellis Pharmaceuticals; and Director, Scientific Communications at Epizyme. She holds a Master of Business Administration (MBA) from Questrom School of Business, Boston University and a Doctor of Philosophy (PhD), Molecular, Cell, Developmental Biology and Genetics from University of Minnesota.

Daisy Lam-McMahon is a regulatory affairs professional with a background spanning biomedical research, gene editing research, and CMC regulatory strategy. At Beam Therapeutics, she supports global regulatory dossiers for genomic medicines and cell therapies, evaluates CMC changes, and contributes to regulatory processes and submissions. She holds a master’s degree in Biomedical Forensic Sciences from Boston University School of Medicine and a bachelor’s degree in Microbiology and Immunology from the University of Miami.

 

Edward Miracco is Head of Enterprise AI Enablement at Moderna. Edward is a scientist and technologist driven by curiosity and a bias for action. His career bridges molecular biology and digital systems, spanning mechanistic enzymology, RNA and oligo chemistry, NMR and cryo-EM structural biochemistry, mRNA process and LNP development, and digital transformation. At Moderna, he helped build the mRNA process platform that enabled the COVID-19 vaccine, led global release and stability operations through mRNA-1273 EUA, and later advanced strategic partnerships and AI-enabled Research and Development. He holds a Doctor of Philosophy (PhD) in Mechanistic Enzymology of RNA Editing Enzymes from University of Delaware.

 

 

Thank you to Soufflé Therapeutics for sponsoring this event.